Sort   by:  
 Page size 
UnknownGiant ankyrin-G stabilizes somatodendritic GABAergic synapses through opposing endocytosis of GABAA receptors.
Not available
S-EPMC4313813 | biostudies-literature
UnknownFrom 'third pole' to north pole: a Himalayan origin for the arctic fox.
Not available
S-EPMC4071559 | biostudies-literature
UnknownImmune landscape in liver of neonatal mice with phlebotomy-induced anemia.
Not available
S-EPMC12659965 | biostudies-literature
UnknownAppoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis.
Not available
S-EPMC4575284 | biostudies-literature
UnknownExpanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome.
Not available
S-EPMC10325952 | biostudies-literature
UnknownNonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.
Not available
S-EPMC12451832 | biostudies-literature
UnknownLong-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study.
Not available
S-EPMC3524372 | biostudies-literature
UnknownThe Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures.
Not available
S-EPMC7783946 | biostudies-literature
UnknownDepressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.
Not available
S-EPMC4397126 | biostudies-literature
UnknownThe Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact.
Not available
S-EPMC12178622 | biostudies-literature
Sort   by:  
 Page size